Tarveda Therapeutics is a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, for the treatment of patients with various solid tumor malignancies.

Biotechnology

Education

Tarveda Therapeutics

Tarveda Therapeutics' headquarters in Watertown, MA, United States

tingting wang

Anudeep Polam

Neil H. Bander

Philip Kantoff

Kapil Dhingra

Gordon B. Mills

Dennis Ausiello

Ralph Weissleder

Robert Langer

Neal Rosen

Karen Hong

Guido Magni

The Advisory Team at Tarveda Therapeutics comprises experienced experts who provide strategic guidance and specialized insights to support the development and clinical advancement of Pentarin® miniature drug conjugates. Their role is pivotal in shaping research directions, optimizing clinical trial designs, and ensuring regulatory compliance to enhance the efficacy and precision of oncology treatments for solid tumor malignancies.

Advisory Team

This department consists of high-level executives overseeing strategic initiatives and organizational direction.

Leadership Group

This department focuses on the exploration and innovation of new products and technologies through scientific research and analysis.

Tarveda Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Group

Research and Development

Offices

Tarveda Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Group

Research and Development

Offices

Related companies